AROMASIN - AN OVERVIEW

If not able to stay clear of coadministration of belzutifan with delicate CYP3A4 substrates, take into consideration escalating the delicate CYP3A4 substrate dose in accordance with its prescribing information and facts. Monitor intently (one)nevirapine will reduce the level or influence of exemestane by affecting hepatic/intestinal enzyme CYP3A4